🔗 Share this article

As the US undertakes historic adjustments to its vaccination recommendations, a particular individual has surfaced unexpectedly: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who rose to prominence by expressing skepticism about coronavirus vaccinations during the global health crisis and has concentrated on potential deaths after COVID-19 vaccination in her brief tenure at the Food and Drug Administration.

Scheduled Shifts to Pediatric Immunization Program

Agency leaders were set to unveil major changes to the childhood vaccination calendar in December, bringing the US with the Danish immunization schedule, sources say – a significant shift that would place the US out of alignment with much of the international standard with insufficient data for benefit. This reveal has been pushed back until the new year.

In place of the director of the vaccine center, Høeg is listed to address the audience at the gathering. She was just designated acting director of the FDA’s CDER, the fifth individual to run the office this calendar year.

A Shift at the Agency

The acting appointment could signify a closer partnership between the drug and vaccine branches as Dr. Høeg and Prasad strengthen their influence at the regulatory agency – and it points to a increased emphasis upon dismantling already-approved vaccines at the FDA.

The new acting director has repeatedly called for ending certain pediatric shot schedules in the US in order to be more similar to Denmark, a society with nationalized medicine and a number of inhabitants approximately the population of the state of Wisconsin.

In her initial public appearances, she has persisted in emphasizing on vaccines – typically the responsibility of Dr. Prasad, head of the FDA’s CBER – as opposed to medication approval.

Questions Over Qualifications

Dr. Høeg has no apparent experience in medication creation, oversight or management, which has been standard for former leaders of the biologics center. She has served at the FDA as a senior adviser to the agency head and the vaccine center since March.

“She appears not to have the requisite experience” for overseeing the pharmaceutical oversight division, said Jonathan Howard. “She’s never run a clinical trial. She lacks experience in leading a large organization. She has no expertise in industry regulation.”

Previous directors of the center would “understand laws and regulations and the research of pharmaceutical innovation”, said Janet Woodcock. “Frankly, she doesn’t have the sort of resume that former directors who headed the center have had.”

This division has an enormous workload at the FDA, she pointed out.

“The public just pays attention on the innovative therapies, but the generic program authorizes a multitude of off-brand pharmaceuticals. There’s a biosimilars program, over-the-counter program and so forth, and every single one need to be managed,” Dr. Woodcock said. “The area you neglect, that is precisely what that I always told people is going to cause problems.”

Furthermore, a significant administrative aspect to the position, which supervises more than 5,000 employees. “It is a enormous leadership role, if you execute it properly,” the former official concluded.

Agency Reaction and Controversial Programs

When asked about questions about Dr. Høeg's credentials and whether this assignment represents more teamwork among agency officials on vaccines, a representative stated that the “questions are based on inaccurate assumptions”.

“Her experience matches the duties of her position,” the official explained, citing the time Høeg spent counseling the FDA commissioner on “drug safety and oversight research, including computational safety modeling and immunization monitoring”.

As the temporary head, Dr. Høeg takes over the agency head's recently launched expedited review system, a disputed expedited therapy clearance system that reportedly worried her preceding directors. “How are these drugs being picked for this expedited pathway? Who is making the choices?” Dr. Howard questioned. “There is a lot of lack of transparency occurring at the regulatory body right now.”

Broadly speaking, he remarked, “the agency looks to be trending towards more relaxed rules of all drugs, aside from shots.”

Documented Past Work on Vaccines

With immunizations, Dr. Høeg has a clearer, if problematic, history, Howard observe. She authored a study using non-validated crowd-sourced reports to determine the rate of myocarditis following COVID-19 immunization. She consulted for the Florida chief medical officer Dr. Joseph Ladapo, who reportedly have altered data to indicate Covid vaccines are more dangerous than they are.

Included in her “policy goals” for the new administration encompassed changing regulations for new vaccines and ending “non-essential” immunizations, she remarked after the election on a audio program. At the agency, Dr. Høeg has allegedly floated the idea of preventing adolescent males from receiving COVID-19 vaccines.

“She’s an thorough true believer who begins with her beliefs and works backwards to accommodate the science in a extremely disingenuous, fraudulent way,” Dr. Howard said.

Consolidating Power and a “Campaign of Retribution”

Dr. Høeg joined fellow contrarians, {like|